VulnerabilityAnalyzed

CVE-2026-41349

OpenClaw before 2026.3.28 contains an agentic consent bypass vulnerability allowing LLM agents to silently disable execution approval via config.patch parameter.

HIGH 8.7EPSS 0.47%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.47%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

OpenClaw before 2026.3.28 contains an agentic consent bypass vulnerability allowing LLM agents to silently disable execution approval via config.patch parameter. Remote attackers can exploit this to bypass security controls and execute unauthorized operations without user consent.

CVSS 4.0: 8.7 HIGHCVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/M
EPSS: 0.47% probability · 40th percentile
CISA KEV: Not listed
Weakness: CWE-862
Affected: openclaw/openclaw
Source: disclosure@vulncheck.com

References

https://github.com/openclaw/openclaw/commit/76411b2afc4ae721e36c12e0ea24fd23e2fed61ePatch
https://github.com/openclaw/openclaw/security/advisories/GHSA-v3qc-wrwx-j3pwPatch, Vendor Advisory
https://www.vulncheck.com/advisories/openclaw-agentic-consent-bypass-via-config-patchThird Party Advisory

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.